ArticleNucleic acids research2025
Label-free technique for universal and sequence independent detection of oligonucleotides and nuclease activity.
Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Nucleases are a diverse group of enzymes cleaving phosphodiester bonds of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) with varying specificity. Depending on the context, nucleases can be considered as unwanted contaminants, molecular biology tools, drug targets, or diagnostic markers. Current methods for nuclease activity monitoring are mainly based on fluorescence detection, by using either labeled substrates or oligonucleotide-binding dyes. These methods are often limited to single- and double-stranded DNA or RNA or the determination of either endo- or exonuclease activity. Universal, simple, and sensitive nucleotide sequence and modification-independent methods, enabling endo- and exonuclease activity monitoring, are not currently available. To address this, we have developed the NucleoProbe technique, as a label-free and substrate-independent option for high-sensitivity endo- or exonuclease activity monitoring. External peptide-probe-based detection utilizing time-resolved luminescence readout enables low nanomolar sensitivity for DNA and RNA oligonucleotides down to 9 nt in length. We also demonstrate the universality by monitoring both endo- and exonuclease activity, with over five-fold improved sensitivity in comparison to our commercial standard assay. Additionally, we show the further potential of the method by specifically detecting S. aureus via its specific micrococcal nuclease activity and, finally, by monitoring nuclease activity from spiked urine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.